CLINIMIX 210 mg/100mL

CLINIMIX 210 mg/100mL is an intravenous injection containing essential amino acids. It is designed to support nutritional needs in patients who cannot consume food orally. This product is manufactured by Baxter Healthcare Corporation in the USA.

CLINIMIX 210 mg/100mL is used to provide essential amino acids to patients who require parenteral nutrition. It is often used in clinical settings where oral intake is not possible or sufficient. The injection contains a blend of amino acids like leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, and alanine, which are crucial for maintaining bodily functions and supporting recovery.

The effects of CLINIMIX 210 mg/100mL are primarily related to its role in providing essential amino acids. These amino acids are vital for various bodily functions, including muscle repair, immune function, and overall metabolic health. Patients may experience improved nutritional status and better recovery outcomes when used as directed by a healthcare professional.

CLINIMIX 210 mg/100mL should be administered under the supervision of a healthcare professional. It is important to follow proper handling and storage guidelines to ensure the product's efficacy and safety. Patients with known allergies to any of the components should avoid using this product. Always consult a healthcare provider before starting any new treatment.

CLINIMIX 210 mg/100mL may interact with other medications or supplements. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Certain medications, such as those affecting electrolyte balance or metabolism, may require careful monitoring when used concurrently with this product.